Recurv Pharma Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies (NCT07504263) | Recurv Pharma Inc | 2026-04-23 |
Track Recurv Pharma Inc automatically
Every clearance here is in the API, with alerts when new ones post.